发布于 2周前 (05-07) Entrepreneurship 阅读:(11) 评论:(0)

Securities Daily News On the evening of May 7, Chengda Pharmaceutical issued an announcement stating that from January 9, 2024 to April 30, 2024, the company had purchased a total of 3,137,500 shares of the company through centralized bidding transactions through a special securities repurchase account, accounting for 2.2% of the company's current total share capital.casinoroulette.03%。

(Article sourcecasinoroulette: Securities Daily)

casinoroulette| Chengda Pharmaceutical: A total of 3137500 shares have been repurchased